Aren't you the member who has been involved in the clinical trials? What information will you give us? Something? Anything?The ignorance here... come on people. The research, methodology, and design between these devices are identical. It is all based on the original guinea pig study done by the University of Minnesota. Y'all know that Shore had to redo her device as well? It's not surprising.
Has anyone followed the link of events?
- The University of Minnesota did the original study.
- Shore picked up on it and moved it forward.
- Neuromod then picked up on it and moved it forward.
- Both Shore and Neuromod fumbled initially.
- Neuromod then brought in the lead researchers from the University of Minnesota to help understand why they failed.
- Shore announces the preliminary success.
- Neuromod announces success and races to put the device on the market (industry first funding).
- Shore wraps up her trial, plans to release device if successful (academic first funding).
- The University of Minnesota moves to phase 3 of a smaller trial of all three but holds the keys to the original experiments and data (just might know something the other two don't).
It's the same tech. It's just a race.
And here we are sooo confused we can't tell our right foot from our left foot. It is laughable. In one sentence you complain that the device isn't released, next you complain you don't have peer-reviewed results. Then you say release the device if it works, then you say you don't want a device released unless you see peer review results. THIS IS NOT LOGIC.
I've tried so hard to help you all understand but apparently, people don't bother reading. Uggh.
Perhaps @Steve might ask for such procedure. Not 100 units but 10 seems reasonable for reporting any effects?If they are so confident in the product, release 100 units to Tinnitus Talk members for review.
Are you thinking "for free"? If so, why would they give away any units for free? I don't think they will have an issue with demand.Perhaps @Steve might ask for such procedure. Not 100 units but 10 seems reasonable for reporting any effects?
According to somebody here it will be available in Ireland from January - however - I would highly recommend people waiting for the evidence base to build up. Products like this with logical science to the usual common man is a selling point, for example, look at Brainsway on Facebook. Lots of likes and 5 star ratings for TMS for treating depression and recently OCD.Is this supposed to be available in January? (At least for most of you in the USA or UK).
Ireland launch apparently in January. UK/rest of EU to follow later. They are also working to get it approved via FDA so they can sell it in the USA.Is this supposed to be available in January? (At least for most of you in the USA or UK).
Little birdie tells me @Steve might be heading over to Ireland for the Q&A as soon as November 28/29, so in a couple of weeks. Once we have the date confirmed, we will announce it, along with creating a new thread where members can submit their questions.@Steve, come on Steve when are they gonna do a Q&A?
Yes and this was from last year so this study has been concluded. Somebody mentioned early on in the thread that they achieved another round of promising results from this, although not released so not to interfere with the peer review. Anyway, we will not know anymore until that is released and until @Steve gets to do a Q&A with them hopefully by the end of this month.I got this from their site. It is a good read.
Phase II – Parameter Optimisation and Patient Subtyping Study:
https://www.neuromoddevices.com/content/1-company/2-clinical-advancement/e018465.full.pdf
Trial design:
The Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A) study is a two-site, randomised, triple-blind, exploratory study examining three different bimodal stimulation parameter sets.
I'm intrigued that Dr. Lim does appear to have ties to the University of Minnesota prior to Neuromod.Was Dr Hubert Lim part of the original team of researchers which was done at the University of Minnesota? If that is the case then that gives a lot of weight to Neuromod's device I think.
http://bme.umn.edu/people/faculty/lim.html
This is some of the work he and his team have worked on:
http://soniclab.umn.edu/
That's actually very comforting if he was part of both devices.I'm intrigued that Dr. Lim does appear to have ties to the University of Minnesota prior to Neuromod.
I don't think they need any marketing at this point. I imagine there's already a line of people who will happily rid them of their initial batch of units. Some are in this very forum!What is the problem of Neuromod offering it for free? This would be the biggest advertisement opportunity for them. Marketing at its best.
Me too. I'm really trying to quell my expectations though so I don't get too depressed if this turns out not to be the answer. I believe this type of device is the only thing in the foreseeable future than can help me. I'm only two months in and struggling to accept that this may be forever.I am hyped for this.
I understand your feeling but your tinnitus is very new. Have hope. Natural improvements may occur.Me too. I'm really trying to quell my expectations though so I don't get too depressed if this turns out not to be the answer.
Yes, @Steve mentioned it in the video from the Tinnitus Expo.I heard rumors that this device has positive effect on hyperacusis?
http://soniclab.umn.edu/research/neural-beamforming-tinnitus@kelpiemsp
Thank you for your post over the weekend.
I am just wondering if/what you know about the devices/technologies from Neuromod/Michigan/Minnesota?
Are they exactly the same or are there minor differences?
Do you know if they work on the same nerve?
Hi @NurseJackie -- Congratulations on getting tinnitus relief!!!
-
Here's another instance where a Parkinson's treatment led to tinnitus suppression...
A stroke of silence: tinnitus suppression following placement of a deep brain stimulation electrode with infarction in area LC.
Abstract
The authors report on a case of tinnitus suppression following deep brain stimulation (DBS) for Parkinson disease. A perioperative focal vascular injury to area LC, a locus of the caudate at the junction of the head and body of the caudate nucleus, is believed to be the neuroanatomical correlate. A 56-year-old woman underwent surgery for implantation of a DBS lead in the subthalamic nucleus to treat medically refractory motor symptoms. She had comorbid tinnitus localized to both ears.
The lead trajectory was adjacent to area LC. Shortly after surgery, she reported tinnitus suppression in both ears. Postoperative MRI showed focal hyperintensity of area LC on T2-weighted images. At 18 months, tinnitus localized to the ipsilateral ear remained completely silenced, and tinnitus localized to the contralateral ear was substantially suppressed due to left area LC injury. To the authors' knowledge, this is the first report of a discrete injury to area LC that resulted in bilateral tinnitus suppression. Clinicians treating patients with DBS may wish to include auditory phantom assessment as part of the neurological evaluation.